CytoSorb setup animation – Post-dialyzer application

CytoSorb setup animation – Post-dialyzer application __________ CytoSorb® is approved in the European Union with distribution in 75 countries around the world. It's indicated for use in conditions where elevated levels of cytokine and/or bilirubin and/or myoglobin exist. CytoSorb is also indicated for use intraoperatively during cardio-pulmonary bypass surgery for removal of the P2Y12 inhibitor Ticagrelor and/or the Factor Xa inhibitor Rivaroxaban. CytoSorb is not commercially available in the USA. This tutorial video shows a possible scenario of the CytoSorb application. The instructions for use of all required components must be observed. The target group for this training module is medical professionals with sufficient qualification for the application of CytoSorb and extracorporeal therapies. CytoSorb and CytoSorbents are trademarks of the CytoSorbents Corporation, USA. Copyright 2026 CytoSorbents Europe GmbH. All rights reserved B2034R02ENG2026.